{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:06:51Z","timestamp":1775225211986,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.therap.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,3,31]],"date-time":"2019-03-31T09:32:55Z","timestamp":1554024775000},"page":"527-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Bullous fixed drug eruption: A potential diagnostic pitfall: a study of 18 cases"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2062-2256","authenticated-orcid":false,"given":"Anissa","family":"Zaouak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Ben Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9lima","family":"Ben Jannet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houda","family":"Hammami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Fenniche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.therap.2019.01.009_bib0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1610-0387.2007.06491.x","article-title":"Fixed drug eruption: state of the art","volume":"6","author":"Ozkaya","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"issue":"8","key":"10.1016\/j.therap.2019.01.009_bib0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-4632.2006.02853.x","article-title":"Fixed drug eruption (FDE): changing scenario of incriminating drugs","volume":"45","author":"Sehgal","year":"2006","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.therap.2019.01.009_bib0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.annder.2015.07.010","article-title":"Fixed pigmented erythema: epidemiology, physiopathology, clinical features, differential diagnosis and therapeutic management","volume":"142","author":"Valeyrie-Allanore","year":"2015","journal-title":"Ann Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.therap.2019.01.009_bib0105","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2013.11.015","article-title":"Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome\/toxic epidermal necrolysis by immunohistopathological features","volume":"70","author":"Cho","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.therap.2019.01.009_bib0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.therap.2016.02.010","article-title":"Causality assessment in pharmacovigilance: the French method and its successive updates","volume":"71","author":"Miremont Salam\u00e9","year":"2016","journal-title":"Therapie"},{"issue":"6","key":"10.1016\/j.therap.2019.01.009_bib0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.therap.2019.01.009_bib0120","doi-asserted-by":"crossref","first-page":"236703","DOI":"10.1155\/2015\/236703","article-title":"Clinical features and drug characteristics of patients with generalized fixed drug eruption in the West of Iran (2005\u20132014)","volume":"2015","author":"Kavoussi","year":"2015","journal-title":"Dermatol Res Pract"},{"issue":"4","key":"10.1016\/j.therap.2019.01.009_bib0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1684\/ejd.2010.0980","article-title":"A three-year-analysis of fixed drug eruptions in hospital settings in France","volume":"20","author":"Brahimi","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"11","key":"10.1016\/j.therap.2019.01.009_bib0130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1365-4362.1998.00451.x","article-title":"Drugs causing fixed eruptions: a study of 450 cases","volume":"37","author":"Mahboob","year":"1998","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.therap.2019.01.009_bib0135","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1525-1470.1995.tb00149.x","article-title":"Clinical pattern of cutaneous drug eruption among children and adolescents in north India","volume":"12","author":"Sharma","year":"1995","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.therap.2019.01.009_bib0140","first-page":"110","article-title":"Fixed drug eruption in infancy","volume":"30","author":"Ramam","year":"1993","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.therap.2019.01.009_bib0145","article-title":"Widespread bullous fixed drug eruption","author":"Patell","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.therap.2019.01.009_bib0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1684\/ejd.2016.2884","article-title":"Illustration of diagnostic and prognostic difficulties during the early stages of generalized bullous fixed drug eruptions","volume":"27","author":"Bataille","year":"2017","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.therap.2019.01.009_bib0155","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jaad.2012.08.019","article-title":"Oral mucosal fixed drug eruption: characteristics and differential diagnosis","volume":"69","author":"\u00d6zkaya","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.therap.2019.01.009_bib0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.annder.2009.12.005","article-title":"Fixed food eruption caused by liquorice","volume":"137","author":"Benomar","year":"2010","journal-title":"Ann Dermatol Venereol"},{"issue":"8\u20139","key":"10.1016\/j.therap.2019.01.009_bib0165","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.annder.2009.06.021","article-title":"Drug patch tests in the investigation of cutaneous adverse drug reactions","volume":"136","author":"Barbaud","year":"2009","journal-title":"Ann Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.therap.2019.01.009_bib0170","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bjd.12133","article-title":"Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"168","author":"Lipowicz","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719300514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719300514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:52:55Z","timestamp":1758567175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595719300514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0040595719300514"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2019.01.009","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bullous fixed drug eruption: A potential diagnostic pitfall: a study of 18 cases","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}